metastatic breast cancer
Showing NaN - NaN of 64
Metastatic Breast Cancer Trial in Worldwide (Placebo, Veliparib, Carboplatin)
Completed
- Metastatic Breast Cancer
- Placebo
- +4 more
-
Birmingham, Alabama
- +119 more
Sep 27, 2021
Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in New York (Pembrolizumab, Flt3L,
Recruiting
- Non-Hodgkin's Lymphoma
- +2 more
- Pembrolizumab
- +3 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Oct 18, 2021
Metastatic Breast Cancer Trial in New York (Ad-RTS-hIL-12, Veledimex)
Completed
- Metastatic Breast Cancer
- Ad-RTS-hIL-12
- Veledimex
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 30, 2021
Associated With First-Line CDK4/6 Inhibition and Hormonal
Not yet recruiting
- Metastatic Breast Cancer
- Palbociclib + aromatase inhibitor
- Aromatase inhibitor
-
New York, New YorkPfizer
Sep 7, 2021
Metastatic Breast Cancer Trial in Puerto Rico, United States (Abemaciclib, Fulvestrant, Standard Chemotherapy)
Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in United States (PMD-026)
Recruiting
- Metastatic Breast Cancer
- Triple Negative Breast Cancer
-
Gilbert, Arizona
- +8 more
Aug 20, 2021
Locally Recurrent Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (NKTR-102, Treatment of Physician's Choice (TPC))
Completed
- Locally Recurrent Breast Cancer
- Metastatic Breast Cancer
- NKTR-102
- Treatment of Physician's Choice (TPC)
-
Flagstaff, Arizona
- +152 more
May 6, 2021
Metastatic Breast Cancer Trial in Worldwide (Atezolizumab, Trastuzumab emtansine, Placebo)
Metastatic Breast Cancer, CNS (CNS) Metastases Trial in United States (Lapatinib in Tandem With Capecitabine)
Completed
- Metastatic Breast Cancer
- Central Nervous System (CNS) Metastases
- Lapatinib in Tandem With Capecitabine
-
Ann Arbor, Michigan
- +8 more
Jan 25, 2021
Metastatic Breast Cancer, Breast Carcinoma Trial in New York (ACY-1215, Nab-paclitaxel)
Completed
- Metastatic Breast Cancer
- Breast Carcinoma
-
New York, New YorkColumbia Irving University Medical Center
Jan 5, 2021
Metastatic Breast Cancer, Locally Recurrent Breast Cancer Trial in Worldwide (Eribulin, Balixafortide)
Unknown status
- Metastatic Breast Cancer
- Locally Recurrent Breast Cancer
-
Fresno, California
- +87 more
Nov 26, 2020
Metastatic Breast Cancer Trial in Worldwide (OPT-822/OPT-821(30 µg/100 µg), Phosphate Buffer Saline (PBS), Cyclophosphamide)
Completed
- Metastatic Breast Cancer
- OPT-822/OPT-821(30 μg/100 μg)
- +2 more
-
Birmingham, Alabama
- +42 more
Sep 14, 2020
Metastatic Breast Cancer Trial in Worldwide (Pertuzumab, Placebo, Trastuzumab)
Metastatic Breast Cancer Trial in New York (Radiation therapy, Study Drug)
Terminated
- Metastatic Breast Cancer
- Radiation therapy
- Study Drug
-
New York, New YorkWeill Cornell Medical College
Nov 20, 2019
Metastatic Breast Cancer Trial in Los Angeles, New York (Fresolimumab, Radiation Therapy)
Completed
- Metastatic Breast Cancer
- Fresolimumab
- Radiation Therapy
-
Los Angeles, California
- +1 more
Feb 21, 2019
Breast Tumor, Breast Cancer, Cancer of the Breast Trial in Worldwide (nab-Paclitaxel, Carboplatin, Gemcitabine)
Metastatic Breast Cancer Trial in New York (ixabepilone)
Completed
- Metastatic Breast Cancer
-
New York, New YorkWeill Medical College of Cornell University
May 31, 2018
Metastatic Breast Cancer Trial in United States (IMC-A12 (cixutumumab), tamoxifen, Anastrozole)
Completed
- Metastatic Breast Cancer
- IMC-A12 (cixutumumab)
- +5 more
-
Scottsdale, Arizona
- +8 more
May 2, 2018
Metastatic Breast Cancer Trial in United States (Fulvestrant, Everolimus, Placebo)
Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer Trial in United States (Abraxane alone, Abraxane +
Completed
- Breast Cancer
- +3 more
- Abraxane alone
- Abraxane + Tigatuzumab
-
Birmingham, Alabama
- +9 more
Oct 24, 2017
Circulating Tumor Cells From Metastatic Breast Cancer Using
Completed
- Metastatic Breast Cancer
- Blood collection
-
Phoenix, Arizona
- +19 more
Mar 7, 2017